Smartkarma AI Primers, Smartkarma

αSK Primers

Smartkarma AI Primers

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

Tabula Rasa Healthcare / Equity Bottom-Up

<ul>
 <li>Tabula Rasa HealthCare (TRHC) was acquired by private equity firm Nautic Partners in November 2023 and subsequently merged with Nautic's portfolio company, ExactCare Pharmacy, to form a new private entity named AnewHealth.</li>
 <li>The company's core intellectual property is the MedWise® technology platform, a sophisticated tool designed to analyze and predict the cumulative risk of multi-drug interactions, thereby reducing adverse drug events, particularly in patients with complex medication regimens.</li>
 <li>Prior to its acquisition, TRHC exhibited a history of significant and persistent net losses and margin pressure, despite revenue growth in earlier years, indicating challenges in achieving operational profitability which likely made it an acquisition target.</li>
</ul>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


  Tabula Rasa HealthCare (TRHC) was acquired by private equity firm Nautic Partners in November 2023 and subsequently merged with Nautic's portfolio company, ExactCare Pharmacy, to form a new private entity named AnewHealth.
  The company's core intellectual property is the MedWise® technology platform, a sophisticated tool designed to analyze and predict the cumulative risk of multi-drug interactions, thereby reducing adverse drug events, particularly in patients with complex medication regimens.
  Prior to its acquisition, TRHC exhibited a history of significant and persistent net losses and margin pressure, despite revenue growth in earlier years, indicating challenges in achieving operational profitability which likely made it an acquisition target.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Primer: Tabula Rasa Healthcare (TRHC US) - May 2026

Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

Tabula Rasa Healthcare / Technical Analysis

Our Group HC-30, Health Care Business Services, is focused on harnessing technology to create solutions that improve patient outcomes and create efficiencies for medical professionals. This recommendation is at the intersection of Health Care, Technology, and Services, with the latter two Sectors being our favorite overweights at this point in time. Below we lay out what we believe is a compelling case to add exposure at current levels.

Our Group HC-30, Health Care Business Services, is focused on harnessing technology to create solutions that improve patient outcomes and create efficiencies for medical professionals. This recommendation is at the intersection of Health Care, Technology, and Services, with the latter two Sectors being our favorite overweights at this point in time. Below we lay out what we believe is a compelling case to add exposure at current levels.

Health Care Business Services Offers Attractive Entry Point -- Add Exposure

United States

Tabula Rasa HealthCare, Inc. designs and develops cloud-based healthcare software solutions. The Company offers data-driven technology and solutions that enable healthcare organizations to optimize medication regimens. Tabula Rasa HealthCare operates in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Tabula Rasa Healthcare (TRHC US)

Primer: Tabula Rasa Healthcare (TRHC US) - May 2026

Tabula Rasa HealthCare (TRHC) was acquired by private equity firm Nautic Partners in November 2023 and subsequently merged with Nautic's...

αSK Primers

Health Care Business Services Offers Attractive Entry Point -- Add Exposure

Our Group HC-30, Health Care Business Services, is focused on harnessing technology to create solutions that improve patient outcomes and create...

Vermilion Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)